N Costedoat-Chalumeau

Summary

Country: France

Publications

  1. ncbi Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block
    N Costedoat-Chalumeau
    Centre Hospitalier, Universitaire Pitié Salpêtrière, Paris, France
    Ann Rheum Dis 62:1010-2. 2003
  2. ncbi [Pleading to maintain hydroxychloroquine throughout Lupus pregnancies]
    N Costedoat-Chalumeau
    Service de Medecine Interne, CHU Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Rev Med Interne 26:467-9. 2005
  3. ncbi Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block
    N Costedoat-Chalumeau
    Service de Medecine Interne, Centre Hospitalier Universitaire Pitie Salpetriere, Paris, France
    Lupus 14:660-4. 2005
  4. ncbi Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options
    Nathalie Costedoat-Chalumeau
    Service de Medecine Interne, Centre Hospitalier Universitaire Pitie Salpetriere, Paris, France
    Arthritis Res Ther 7:69-73. 2005
  5. ncbi Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature
    Nathalie Costedoat-Chalumeau
    Service de Medecine Interne, Centre Hospitalier Universitaire Pitie Salpetriere, 47 83 boulevard de l Hopital, 75651 Paris Cedex 13, France
    Autoimmun Rev 4:111-5. 2005
  6. ncbi [Obstetrical management of patients at risk of neonatal lupus syndrome: review of the literature]
    N Costedoat-Chalumeau
    Service de Medecine Interne, CHU Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75651 Paris Cedex 13
    J Gynecol Obstet Biol Reprod (Paris) 35:146-56. 2006
  7. ncbi Cardiomyopathy related to antimalarial therapy with illustrative case report
    Nathalie Costedoat-Chalumeau
    Service de Medecine Interne, Centre Hospitalier Universitaire Pitie Salpetriere, Paris, France
    Cardiology 107:73-80. 2007
  8. ncbi Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group
    Nathalie Costedoat-Chalumeau
    Centre Hospitalier Universitaire Pitie Salpetriere, Paris, France
    Arthritis Rheum 50:3187-94. 2004
  9. ncbi Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group
    Nathalie Costedoat-Chalumeau
    Centre Hospitalier Universitaire Pitie Salpetriere, Paris, France
    Arthritis Rheum 48:3207-11. 2003
  10. ncbi [Neonatal lupus syndrome: review of the literature]
    N Costedoat-Chalumeau
    Service de Medecine Interne, Centre Hospitalier Universitaire Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Rev Med Interne 24:659-71. 2003

Detail Information

Publications50

  1. ncbi Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block
    N Costedoat-Chalumeau
    Centre Hospitalier, Universitaire Pitié Salpêtrière, Paris, France
    Ann Rheum Dis 62:1010-2. 2003
    ..Mothers with anti-SSA/Ro antibodies who have had a previous fetus with congenital heart block (CHB) have a risk of recurrence estimated to be up to 16%...
  2. ncbi [Pleading to maintain hydroxychloroquine throughout Lupus pregnancies]
    N Costedoat-Chalumeau
    Service de Medecine Interne, CHU Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Rev Med Interne 26:467-9. 2005
    ..Further studies with prospective follow-up of children exposed in utero to HCQ remain however needed to provide a definitive answer...
  3. ncbi Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block
    N Costedoat-Chalumeau
    Service de Medecine Interne, Centre Hospitalier Universitaire Pitie Salpetriere, Paris, France
    Lupus 14:660-4. 2005
    ..Curative treatment of CHB is based on fluorinated steroids (dexamethasone or betamethasone) that do cross the placenta in an active form. Guidelines are available but further studies are needed to optimize treatment...
  4. ncbi Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options
    Nathalie Costedoat-Chalumeau
    Service de Medecine Interne, Centre Hospitalier Universitaire Pitie Salpetriere, Paris, France
    Arthritis Res Ther 7:69-73. 2005
    ..Treatment of CHB is not well established and needs to be assessed carefully. The risks and benefits of prenatal fluorinated steroids are discussed...
  5. ncbi Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature
    Nathalie Costedoat-Chalumeau
    Service de Medecine Interne, Centre Hospitalier Universitaire Pitie Salpetriere, 47 83 boulevard de l Hopital, 75651 Paris Cedex 13, France
    Autoimmun Rev 4:111-5. 2005
    ..However, the amount of HCQ received by children through lactation seems very low. In conclusion, HCQ should probably be maintained throughout pregnancy in patients with SLE and it does not seem necessary to advise against breastfeeding...
  6. ncbi [Obstetrical management of patients at risk of neonatal lupus syndrome: review of the literature]
    N Costedoat-Chalumeau
    Service de Medecine Interne, CHU Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75651 Paris Cedex 13
    J Gynecol Obstet Biol Reprod (Paris) 35:146-56. 2006
    ..Electrocardiogram should be performed in the first days of life for all children to detect incomplete CHB. Therapy for CHB detected in utero is based on fluorinated steroids, especially betamethasone. Its efficiency is variable...
  7. ncbi Cardiomyopathy related to antimalarial therapy with illustrative case report
    Nathalie Costedoat-Chalumeau
    Service de Medecine Interne, Centre Hospitalier Universitaire Pitie Salpetriere, Paris, France
    Cardiology 107:73-80. 2007
    ....
  8. ncbi Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group
    Nathalie Costedoat-Chalumeau
    Centre Hospitalier Universitaire Pitie Salpetriere, Paris, France
    Arthritis Rheum 50:3187-94. 2004
    ..To assess the pathologic nature of these manifestations, this study focused on electrocardiographic (EKG) variations in these children, comparing them with findings in a control group...
  9. ncbi Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group
    Nathalie Costedoat-Chalumeau
    Centre Hospitalier Universitaire Pitie Salpetriere, Paris, France
    Arthritis Rheum 48:3207-11. 2003
    ..We now report our experience with 133 pregnancies in women being treated with HCQ, resulting in 117 live births. Results in the HCQ group are compared with those in a control group...
  10. ncbi [Neonatal lupus syndrome: review of the literature]
    N Costedoat-Chalumeau
    Service de Medecine Interne, Centre Hospitalier Universitaire Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Rev Med Interne 24:659-71. 2003
    ..FUTURE PROSPECTS AND PROJECTS: The efficiency of prophylactic treatment of CHB is not established. Therapy for CHB detected in utero is not standardized and involves fluorinated steroids (especially betamethasone)...
  11. ncbi [Vitamin D and autoimmunity. Second part: Clinical aspects]
    Y Schoindre
    Service de Medecine Interne, Université Versailles Saint Quentin en Yvelines, Hopital Foch, 40, rue Worth, 92151 Suresnes Cedex, France
    Rev Med Interne 33:87-93. 2012
    ....
  12. ncbi Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases
    N Costedoat-Chalumeau
    AP HP Service de Médecine Interne, Centre de Reference National Pour les Lupus et le Syndrome des Antiphospholipides, Centre Hospitalier Universitaire Pitie Salpetriere, Paris Cedex 13, France
    Rheumatology (Oxford) 46:808-10. 2007
    ..Since no data were available for HCQ, we studied electrocardiograms (ECGs) in 85 unselected patients with CTD treated with HCQ as the sole antimalarial...
  13. ncbi [Pregnancy and antiphospholipid syndrome]
    N Costedoat-Chalumeau
    Service de Medecine Interne, Centre de Référence National pour le Lupus Systémique et le Syndrome des Antiphospholipides, Hopital Pitie Salpetriere, AP HP, Universite Pierre et Marie Curie Paris 6, 47 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Rev Med Interne 33:209-16. 2012
    ..Treatment optimization and multidisciplinary antenatal care improve the prognosis of pregnancies in women with obstetric APS, leading to a favorable outcome most of the time...
  14. ncbi The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature
    M Jallouli
    Centre Hospitalier Universitaire Pitie Salpetriere, Universite Paris 6, AP HP, Paris, France
    J Neurol 259:1290-7. 2012
    ..Hydroxychloroquine treatment appears to be safe in this setting...
  15. ncbi [Catastrophic antiphospholipid syndrome]
    N Costedoat-Chalumeau
    Service de Medecine Interne, Centre de Référence National pour le Lupus Systémique et le Syndrome des Antiphospholipides, faculté Paris 6, Hopital Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75013 Paris, France
    Rev Med Interne 33:194-9. 2012
    ..The prevention of CAPS is based upon the adequate management of the perioperative period when surgery cannot be avoided, the prompt treatment of infections and the education of patients with antiphospholipid syndrome...
  16. ncbi AL cardiac amyloidosis and arterial thromboembolic events
    P Hausfater
    Emergency Department, Pitie Salpetriere University Hospital Centre, 75651 Paris Cedex 13, France
    Scand J Rheumatol 34:315-9. 2005
    ..To study the prevalence and characteristics of arterial thromboembolic events (ATEE) in the course of AL amyloidosis...
  17. ncbi [Critical review of the new recommendations on screening for hydroxychloroquine retinopathy]
    N Costedoat-Chalumeau
    Service de Medecine Interne, Centre de Reference National Pour les Lupus et le Syndrome des Antiphospholipides, CHU Pitie Salpetriere, AP HP, Universite Paris VI, 47 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Rev Med Interne 33:265-7. 2012
    ..A baseline examination is advised as a reference and then, annual screening should be initiated no later than 5 years after starting hydroxychloroquine therapy...
  18. ncbi Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone
    N Costedoat-Chalumeau
    Groupe Hospitalier Universitaire Pitié Salpêtrière, Paris, France
    Ann Intern Med 132:631-5. 2000
    ..Oral anticoagulants and pulse high-dose intravenous methylprednisolone are often administered concomitantly, but no data on potential interactions are available...
  19. ncbi Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature
    G Leroux
    Department of Internal Medicine, Centre Hospitalier Universitaire Pitie Salpetriere, 83 Boulevard de l hopital, 75013 Paris, France
    Lupus 17:139-47. 2008
    ..The hypertension and other worsening factors should be treated. Finally, the evolution of this clinical and radiological spectacular syndrome is generally rapidly favorable...
  20. ncbi [Management of antiphospholipid syndrome]
    D Saadoun
    Service de Medecine Interne, centre de référence national pour le lupus et le syndrome des antiphospholipides, CHU Pitie Salpetriere, AP HP, Universite Pierre et Marie Curie Paris 6, 47 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Rev Med Interne 33:217-22. 2012
    ..5. The possible occurrence of relapse despite anticoagulation in the therapeutic target may lead to the addition of aspirin. The development of new anti-thrombotic agents might change the management of APS in the coming years...
  21. ncbi [Liver disease and pregnancy]
    C Delluc
    Centre de Référence National pour le Lupus Systémique et le Syndrome des Antiphospholipides, Service de Medecine Interne, Hopital Pitie Salpetriere, Assistance Publique Hopitaux de Paris, 47 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Rev Med Interne 30:508-15. 2009
    ..Management of liver disease can be different during pregnancy. The knowledge of liver dysfunction during pregnancy is of help for a better management of the mother in order to avoid maternal and fetal mortality and morbidity...
  22. ncbi [Hydroxychloroquine and systemic lupus: a reappraisal]
    N Costedoat-Chalumeau
    Université de Pierre et Marie Curie Paris 6, Centre de Reference National Pour les Lupus et le Syndrome des Antiphospholipides, centre hospitalier universitaire de la Pitié Salpêtrière, Paris, France
    Rev Med Interne 29:735-7. 2008
    ..Hydroxychloroquine (HCQ) is still too often considered as a second-line treatment in systemic lupus erythematosus (SLE) patients...
  23. ncbi [Central serous chorioretinopathy and systemic diseases report of 2 cases associated with corticotherapy]
    A Bouyon
    , , 47-83, , 75651 Paris Cedex 13, France
    Rev Med Interne 27:487-91. 2006
    ..CONCLUSION: Similarly to cataract or glaucoma, central serous chorioretinopathy belongs to the potential ocular side-effect of steroid treatment, and thus deserves to be known by internists...
  24. ncbi [Vitamin D and autoimmunity. First part: Fundamental aspects]
    Y Schoindre
    Service de Medecine Interne, Université Versailles Saint Quentin en Yvelines, Hopital Foch, 40, rue Worth, 92151 Suresnes Cedex, France
    Rev Med Interne 33:80-6. 2012
    ..The authors present their actions on myeloid dendritic cells, T cells, B cells, as well as on the synthesis of antimicrobial peptides and autophagy, and the potential beneficial effects in autoimmune and inflammatory diseases...
  25. ncbi [Spleen and liver nodules]
    J Cohen-Bittan
    , , 47-83, , 75651 Paris Cedex 13, France
    Rev Med Interne 28:420-1. 2007
  26. ncbi Tumor antigen markers for the detection of solid cancers in inflammatory myopathies
    Zahir Amoura
    Service de Medecine Interne, Hopital Pitie Salpetriere, 47 83 Bd de l Hopital, 75013 Paris, France
    Cancer Epidemiol Biomarkers Prev 14:1279-82. 2005
    ....
  27. ncbi Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review
    Julien Haroche
    Service de Medecine Interne, Hopital Pitie Salpetriere, Paris, France
    Medicine (Baltimore) 83:371-92. 2004
    ..Data concerning follow-up were available for 58 (80.6%) patients. Of these, 35 (60.3%) patients died, confirming the severe prognosis of ECD. Cardiovascular complications were responsible for the death of 11 of the 35 patients (31.4%)...
  28. ncbi Cryoglobulinemia vasculitis
    Patrice Cacoub
    Service de Medecine Interne, hôpital La Pitié Salpêtrière, Paris, France
    Curr Opin Rheumatol 14:29-35. 2002
    ....
  29. ncbi Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome
    Zahir Amoura
    Centre Hospitalier Universitaire Pitie Salpetriere, Paris, France
    Arthritis Rheum 50:3260-4. 2004
    ..Our findings suggest that primary APS must be added to the list of autoimmune disorders that can be complicated by TTP...
  30. ncbi Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy
    C Lebaudy
    Pharmacology Department, Pitie Salpetriere Hospital, AP HP, Paris, France
    Clin Pharmacol Ther 84:370-7. 2008
    ..We recommend the administration of doses normalized for body weight changes so as to counteract enoxaparin pharmacokinetic changes that accompany various stages of pregnancy...
  31. ncbi [A vertebroplasty with dyspnea]
    G Leroux
    , , 75651 Paris Cedex 13, France
    Rev Med Interne 28:492-4. 2007
  32. ncbi [Scurvy]
    A Bouyon
    , , 47-83, , 75651 Paris Cedex 13, France
    Rev Med Interne 25:934-5. 2004
  33. ncbi [Edematous syndrome revealing an exudative lymphocytic gastritis: efficacy of omeprazole]
    P Cacoub
    Service de Medecine Interne, Hopital de la Pitie Salpetriere, Paris
    Gastroenterol Clin Biol 24:963-4. 2000
    ..Inflammatory involvement of the gastric mucosa probably caused protein losing in this patient. Recognition of this exsudative gastropathy is important because long term remission is obtained with omeprazole...
  34. ncbi Impact of antiphosholipid biology in maternal Down syndrome screening
    Christine Brochet
    UF d Oncobiochimie et Biochimie Prénatale, GH Pitié Salpétrière, AP HP, Paris, France
    Prenat Diagn 29:481-8. 2009
    ..Because AFP is involved in the calculation of the risk of trisomy 21 (T21), we studied the effect of AFP variations in the presence of aPL during T21 screening...
  35. ncbi Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus
    A Mathian
    Centre de Reference National Pour les Lupus et le Syndrome des Antiphospholipides, Groupement Hospitalier Pitié Salpêtrière, AP HP, Universite Pierre et Marie Curie, université Paris 06, and INSERM UMR S 945, Paris, France
    Arthritis Rheum 63:3502-11. 2011
    ..To assess the factors influencing the efficacy of 2 injections of a pandemic 2009 influenza A (H1N1) vaccine in patients with systemic lupus erythematosus (SLE)...
  36. ncbi Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus
    Nathalie Costedoat-Chalumeau
    AP HP, Service de Medecine Interne, Centre de Référence National pour le Lupus Systémique et le Syndrome des Antiphospholipides, CHU Pitie Salpetriere, 47 83 boulevard de l Hopital, 75651 Paris Cedex 13, France
    Ann Rheum Dis 66:821-4. 2007
    ..Poor adherence to treatment is difficult to diagnose accurately. Hydroxychloroquine (HCQ) has a long elimination half-life and its concentration in whole blood can be measured easily...
  37. ncbi Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database
    Christian Pagnoux
    Universite Paris Descartes, Hopital Cochin, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 62:616-26. 2010
    ..This study was undertaken to describe the main characteristics of and long-term outcomes in patients with well-characterized PAN diagnoses...
  38. ncbi [Sarcomania has its limits!]
    A Birenbaum
    , , 47-83, , 75651 Paris Cedex 13, France
    Rev Med Interne 25:S231-3. 2004
  39. ncbi Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus
    Nathalie Costedoat-Chalumeau
    Assistance Publique Hopitaux de Paris, Centre Hospitalier Universitaire Pitie Salpetriere, Universite Paris VI Pierre et Marie Curie, Paris, France
    Arthritis Rheum 54:3284-90. 2006
    ..To study the possible relationship between whole-blood hydroxychloroquine (HCQ) concentrations and clinical efficacy of HCQ in patients with systemic lupus erythematosus (SLE)...
  40. ncbi Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, North African, and black patients
    Laurent Arnaud
    Service de Medecine Interne, Hopital Pitie Salpetriere, AP HP, Universite Paris 6, Paris, France
    Medicine (Baltimore) 89:1-17. 2010
    ..North African patients have a higher occurrence of ischemic stroke and poorer survival than white patients...
  41. ncbi Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis
    Jeremie Sellam
    Service de Medecine Interne, Centre Hospitalier Universitaire Pitie Salpetriere, Universite Paris VI Pierre et Marie Curie, Centre de Reference National Pour les Lupus et le Syndrome des Antiphospholipides, Paris, France
    Joint Bone Spine 74:446-52. 2007
    ....
  42. ncbi Hydroxychloroquine blood assay as a marker of nonadherence in patients with systemic lupus erythematosus: comment on the article by Koneru et al
    Nathalie Costedoat-Chalumeau
    Arthritis Rheum 59:153; author reply 153-4. 2008
  43. ncbi Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseases
    Gaëlle Leroux
    Ann Rheum Dis 66:1547-8. 2007
  44. ncbi Corrected QT interval in anti-SSA-positive adults with connective tissue disease: comment on the article by Lazzerini et al
    Nathalie Costedoat-Chalumeau
    Arthritis Rheum 52:676-7; author reply 677-8. 2005
  45. ncbi Evidence of transplacental passage of hydroxychloroquine in humans
    Nathalie Costedoat-Chalumeau
    , Paris, France
    Arthritis Rheum 46:1123-4. 2002
  46. ncbi Hemophagocytic syndrome in a pregnant patient with systemic lupus erythematosus, complicated with preeclampsia and cerebral hemorrhage
    Laurent Perard
    Ann Hematol 86:541-4. 2007
  47. ncbi Hydroxychloroquine in systemic lupus erythematosus
    Nathalie Costedoat-Chalumeau
    Lancet 369:1257-8. 2007
  48. ncbi Drug-induced hemophagocytosis
    Olivier Lambotte
    Am J Med 112:592-3. 2002
  49. ncbi [We don't beat around the bush anymore]]
    F Badet
    , Centre Hospitalier Lyon-Sud, , France
    Rev Med Interne 26:S197-9. 2005
  50. ncbi [Cystadenoma of the liver with high levels of ACE and CA 19-9 in the cyst]
    Christophe Tresallet
    Service de Chirurgie Generale, digestive et endocrinienne, Hopital de la Pitie, 47 83 boulevard de l Hopital, 75651 Paris Cedex 13
    Gastroenterol Clin Biol 27:413-5. 2003
    ..Definitive histological evaluation is the only means to discriminate malignant from benign cysts. We report a case of cystadenoma of the liver with very high cystic levels and normal serum levels of CEA and CA 19-9...